Biomimetic nanobubbles for triple-negative breast cancer targeted ultrasound molecular imaging
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-3155
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Biomimetic nanobubbles for triple-negative breast cancer targeted ultrasound molecular imaging ; volume:20 ; number:1 ; day:10 ; month:6 ; year:2022 ; pages:1-14 ; date:12.2022
Journal of nanobiotechnology ; 20, Heft 1 (10.6.2022), 1-14, 12.2022
- Creator
-
Jugniot, Natacha
Massoud, Tarik F.
Dahl, Jeremy J.
Paulmurugan, Ramasamy
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12951-022-01484-9
- URN
-
urn:nbn:de:101:1-2022080619022550214665
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jugniot, Natacha
- Massoud, Tarik F.
- Dahl, Jeremy J.
- Paulmurugan, Ramasamy
- SpringerLink (Online service)
Other Objects (12)
Recent advances in targeted strategies for triple-negative breast cancer
Targeted therapies for the treatment of triple-negative breast cancer
Biomimetic oxygen delivery nanoparticles for enhancing photodynamic therapy in triple-negative breast cancer
Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Hyaluronic acid-functionalized supramolecular nanophotosensitizers for targeted photoimmunotherapy of triple-negative breast cancer
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Recent advances in targeted strategies for triple-negative breast cancer
Targeted therapies for the treatment of triple-negative breast cancer
Biomimetic oxygen delivery nanoparticles for enhancing photodynamic therapy in triple-negative breast cancer
Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Hyaluronic acid-functionalized supramolecular nanophotosensitizers for targeted photoimmunotherapy of triple-negative breast cancer
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Recent advances in targeted strategies for triple-negative breast cancer
Targeted therapies for the treatment of triple-negative breast cancer
Biomimetic oxygen delivery nanoparticles for enhancing photodynamic therapy in triple-negative breast cancer
Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Hyaluronic acid-functionalized supramolecular nanophotosensitizers for targeted photoimmunotherapy of triple-negative breast cancer
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
Characterizing triple-negative breast cancer tumors